BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 32934044)

  • 1. Modulating the gut-liver axis and the pivotal role of the faecal microbiome in cirrhosis.
    Woodhouse C; Singanayagam A; Patel VC
    Clin Med (Lond); 2020 Sep; 20(5):493-500. PubMed ID: 32934044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiota, cirrhosis, and the emerging oral-gut-liver axis.
    Acharya C; Sahingur SE; Bajaj JS
    JCI Insight; 2017 Oct; 2(19):. PubMed ID: 28978799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The gut-liver axis in liver disease: Pathophysiological basis for therapy.
    Albillos A; de Gottardi A; Rescigno M
    J Hepatol; 2020 Mar; 72(3):558-577. PubMed ID: 31622696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promises of microbiome-based therapies.
    Bajaj JS; Ng SC; Schnabl B
    J Hepatol; 2022 Jun; 76(6):1379-1391. PubMed ID: 35589257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of gut microbiota in the pathogenesis and therapeutics of minimal hepatic encephalopathy
    Luo M; Xin RJ; Hu FR; Yao L; Hu SJ; Bai FH
    World J Gastroenterol; 2023 Jan; 29(1):144-156. PubMed ID: 36683714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The gut-liver axis in immune remodeling of hepatic cirrhosis.
    Guan H; Zhang X; Kuang M; Yu J
    Front Immunol; 2022; 13():946628. PubMed ID: 37408838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis.
    Maslennikov R; Ivashkin V; Efremova I; Poluektova E; Kudryavtseva A; Krasnov G
    World J Gastroenterol; 2022 Mar; 28(10):1067-1077. PubMed ID: 35431497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered Microbiome in Patients With Cirrhosis and Complications.
    Acharya C; Bajaj JS
    Clin Gastroenterol Hepatol; 2019 Jan; 17(2):307-321. PubMed ID: 30099098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis.
    Bajaj JS; Khoruts A
    J Hepatol; 2020 May; 72(5):1003-1027. PubMed ID: 32004593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intestinal microbiota on liver disease and its related future prospection: From the perspective of intestinal barrier damage and microbial metabolites.
    Jiang N; Xiao Y; Yuan K; Wang Z
    J Gastroenterol Hepatol; 2023 Jul; 38(7):1056-1071. PubMed ID: 36662612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human microbiome and gut-liver axis in people living with HIV.
    Duarte MJ; Tien PC; Somsouk M; Price JC
    Curr HIV/AIDS Rep; 2023 Jun; 20(3):170-180. PubMed ID: 37129834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Microbiota and Complications of Liver Disease.
    Acharya C; Bajaj JS
    Gastroenterol Clin North Am; 2017 Mar; 46(1):155-169. PubMed ID: 28164848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota and host metabolism in liver cirrhosis.
    Usami M; Miyoshi M; Yamashita H
    World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Link between Gut Microbiota and Hepatic Encephalopathy.
    Won SM; Oh KK; Gupta H; Ganesan R; Sharma SP; Jeong JJ; Yoon SJ; Jeong MK; Min BH; Hyun JY; Park HJ; Eom JA; Lee SB; Cha MG; Kwon GH; Choi MR; Kim DJ; Suk KT
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol, liver disease and the gut microbiota.
    Bajaj JS
    Nat Rev Gastroenterol Hepatol; 2019 Apr; 16(4):235-246. PubMed ID: 30643227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease.
    Woodhouse CA; Patel VC; Singanayagam A; Shawcross DL
    Aliment Pharmacol Ther; 2018 Jan; 47(2):192-202. PubMed ID: 29083037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of the Gut Microbiome in Liver Cirrhosis Treatment.
    Lee NY; Suk KT
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33379148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis.
    Nishikawa H; Enomoto H; Nishiguchi S; Iijima H
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32722100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.
    Arab JP; Martin-Mateos RM; Shah VH
    Hepatol Int; 2018 Feb; 12(Suppl 1):24-33. PubMed ID: 28550391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Interplay between Gut Microbiota and the Immune System in Liver Transplant Recipients and Its Role in Infections.
    Ancona G; Alagna L; Lombardi A; Palomba E; Castelli V; Renisi G; Dondossola D; Iavarone M; Muscatello A; Gori A; Bandera A
    Infect Immun; 2021 Oct; 89(11):e0037621. PubMed ID: 34460287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.